Evidence map›Paper›PMID 42649893›Full record

ArticleCancers2026

Nationwide Characteristics of Patients Admitted to Hospital for the First Time Due to Primary Liver Cancer and Intrahepatic Bile Duct Cancer in Poland in 2012-2023.

Agnieszka Genowska, Jerzy Jaroszewicz, Dorota Zarębska-Michaluk, Katarzyna Lewtak, Krystyna Dobrowolska, Krzysztof Kanecki, Anna Parfieniuk-Kowerda, Aneta Nitsch-Osuch, Piotr Rzymski, Robert Flisiak

Abstract read
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Agnieszka GenowskaDepartment of Public Health, Medical University of Bialystok, 15-295 Bialystok, Poland.ORCID 0000-0002-1432-1062
Jerzy JaroszewiczDepartment of Infectious Diseases and Hepatology, Medical University of Silesia, 40-055 Katowice, Poland.
Dorota Zarębska-MichalukDepartment of Infectious Diseases and Allergology, Jan Kochanowski University, 25-317 Kielce, Poland.ORCID 0000-0003-0938-1084
Katarzyna LewtakDepartment of Social Medicine and Public Health, Medical University of Warsaw, 00-106 Warsaw, Poland.ORCID 0000-0002-2996-583X
Krystyna DobrowolskaCollegium Medicum, Jan Kochanowski University, 25-317 Kielce, Poland.ORCID 0000-0003-0352-9893
Krzysztof KaneckiDepartment of Social Medicine and Public Health, Medical University of Warsaw, 00-106 Warsaw, Poland.ORCID 0000-0001-8931-8565
Anna Parfieniuk-KowerdaDepartment of Infectious Diseases and Hepatology, Medical University of Bialystok, 15-540 Bialystok, Poland.
Aneta Nitsch-OsuchDepartment of Social Medicine and Public Health, Medical University of Warsaw, 00-106 Warsaw, Poland.
Piotr RzymskiDepartment of Environmental Medicine, Poznan University of Medical Sciences, 60-806 Poznan, Poland.ORCID 0000-0002-4713-0801
Robert FlisiakDepartment of Infectious Diseases and Hepatology, Medical University of Bialystok, 15-540 Bialystok, Poland.

Funding

Medical University of Białystok B.SUB.26.214
6 · The paper itself

Abstract

BACKGROUND/

objectivesPrimary liver and intrahepatic bile duct cancers remain important causes of cancer morbidity and mortality worldwide, yet contemporary nationwide data on affected populations in Poland are limited. This study evaluated sociodemographic patterns of first-time hospitalizations due to malignant neoplasms of the liver and intrahepatic bile ducts in Poland during 2012-2023.

methodsData were obtained from the Nationwide General Hospital Morbidity Study and included 30,898 first-time hospitalizations identified using the ICD-10 category C22. First-time hospitalization rates were assessed according to sex, age, place of residence, disease subtype, length of stay, and comorbidities.

resultsMen accounted for 57.7% of urban and 58.4% of rural cases and had significantly higher first-time hospitalization rates than women. These rates were higher among urban than rural residents (men: 9.5 vs. 6.0 per 100,000; women: 6.3 vs. 4.2 per 100,000). Liver cell carcinoma was the most frequent subtype (36.3%), followed by intrahepatic bile duct carcinoma (12.6%). Hospitalizations were uncommon before the age of 40 years and peaked in the 65-69-year age group. Mean age increased over time among men and urban women. In 2020, the number of first-time hospitalizations decreased from 2754 to 2060, corresponding to 694 fewer hospitalizations and a 25.2% decline compared with 2019. This decrease occurred against the background of nationwide reductions of 22.1% in patients treated in general-hospital wards and 8.1% in oncology-ward patients, suggesting that pandemic-related healthcare disruption may have contributed to the observed decline. Hospitalization rates subsequently increased. Rates for liver cell carcinoma remained relatively stable in most population groups, whereas those for intrahepatic bile duct carcinoma were significantly higher in 2020-2023 than in 2012-2019 across all sex and place-of-residence groups. Length-of-stay patterns were broadly similar across the analyzed groups, and diseases of the digestive system were the most common comorbidity category (23.1%).

conclusionsThe findings demonstrate important sociodemographic differences and temporal changes in first-time hospitalizations due to malignant neoplasms of the liver and intrahepatic bile ducts in Poland. These findings suggest evolving epidemiological patterns and underscore the need for continued prevention, surveillance, and early detection efforts.

Indexed as

cholangiocarcinomaepidemiologyhepatocellular carcinomahospitalizationliver neoplasmsPoland

Identifiers

PMID42649893
PMCPMC13511573

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.